NASDAQ : SLBT

SL Science Holding Ltd

$4.23 USD

-$0.07 (-1.63%)

Volume
21.7K
Average Volume
731.51K
Market Capitalization
$33.49M
P/E Ratio
0.00
Dividend Yield
0.00%
Price Target
Year High
$14.50
Year Low
$3.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$3.05
Company Overview

NASDAQ

Mingyu Li

Biotechnology

Healthcare

SLBT

2

US

USD

1 646 257-5537

G8191L116

0002070534

Liquidity Metrics

0.09

3.05

3.05

2.69

0.00

Sales & Valuation

$2.2M

15.24

0.00

-15.02

0.00

Profitability

$0

-$3.82M

-173.85%

-173.85%

-95.36%

-135.59%

P/E Metrics

0.00

0.00

0.00

Analyst Price Target & Rating

Strong Sell

1/5

0 Analysts

%

Poll Results

No votes yet today — be the first to share your view!

About SL Science Holding Ltd (NASDAQ:SLBT) Stock

Horizon Space Acquisition II Corp. aims to achieve strategic business combinations with other companies. This objective can be fulfilled through various transactional structures, including mergers, exchanges of shares, acquisitions of assets, direct purchases of stock, recapitalizations, or other forms of corporate reorganization. The firm was founded in 2023 and maintains its headquarters in New York, New York. ...

SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology

2026-07-17 08:00:00

Joint presentation with Taipei Medical University, JY BioMed, and HeXun Biosciences highlighted the power of gamma delta (γδ) T cells in eliminating glioblastoma in preclinical studies.

SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma

2026-07-10 08:00:00

Taipei, TAIWAN, July 10, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited (“SL Science” or the “Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced that the Company has submitted an Orphan Drug Designation (ODD) request to the U.S. Food and Drug Administration (FDA) for its Gamma Delta T (GDT) cell therapy product, Vdelta2+ Gamma Delta T Cells, for the treatment of glioblastoma multiforme (GBM). The FDA's Office of Orphan Products Development (OOPD) has formally acknowledged receipt of the request and is proceeding with review on additional files about the product

SL Science Holding, Alamos Gold And Other Big Stocks Moving Lower In Monday's Pre-Market Session

2026-06-22 08:02:04

U.S. stock futures were mixed this morning, with the S&P 500 futures falling around 0.1% on Monday.

SL Science Holding Limited Reports Full Year 2025 Financial Results

2026-06-18 17:13:18

Taipei, TAIWAN, June 18, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited ("SL Science" or the "Company") (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced its financial results for the full year ended December 31, 2025.

SL BIO Ltd. and Horizon Space Acquisition II Announce Closing of Business Combination and Listing on the Nasdaq Global Market

2026-06-12 14:51:00

TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the closing of its previously announced business combination with Horizon Space Acquisition II Corp. (Nasdaq: HSPT) (“Horizon Space”), a publicly traded special purpose acquisition company.

Frequently Asked Questions

What is the current SL Science Holding Ltd (SLBT) stock price?

SL Science Holding Ltd(NASDAQ:SLBT) stock price is $4.23 in the last trading session. During the trading session, SLBT stock reached the peak price of $14.5 while $3 was the lowest point it dropped to. The percentage change in SLBT stock occurred in the recent session was --1.63% while the dollar amount for the price change in SLBT stock was -$0.07.

SLBT's industry and sector of operation?

The NASDAQ listed SLBT is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of SLBT?

Ray Leung | CFO & Director
Ethan Shen | CTO & Director
Ching-Dong Wang | Founder, Chairman & CEO
|
|

How many employees does SLBT have?

Number of SLBT employees currently stands at 2. SLBT operates from 1412 Broadway, New York, NY 10018, US.

Link for SLBT official website?

Official Website of SLBT is: https://www.horizonacquisitionii.com

How do I contact SLBT?

SLBT could be contacted at phone #1 646 257-5537 and can also be accessed through its website. SLBT operates from 1412 Broadway, New York, NY 10018, US.

How many shares of SLBT are traded daily?

The average number of SLBT shares traded daily for last 3 months was 731.51K.

What is the market cap of SLBT currently?

The market value of SLBT currently stands at $33.49M with its latest stock price at $4.23